BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16504804)

  • 1. The genetic heterogeneity of uterine leiomyomata.
    Lobel MK; Somasundaram P; Morton CC
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):13-39. PubMed ID: 16504804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
    Hodge JC; Morton CC
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetics of uterine leiomyomata].
    Pedeutour F; Ligon AH; Morton CC
    Bull Cancer; 1999 Nov; 86(11):920-8. PubMed ID: 10586108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression studies in leiomyomata: new directions for research.
    Catherino W; Salama A; Potlog-Nahari C; Leppert P; Tsibris J; Segars J
    Semin Reprod Med; 2004 May; 22(2):83-90. PubMed ID: 15164303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of uterine leiomyomata.
    Ligon AH; Morton CC
    Genes Chromosomes Cancer; 2000 Jul; 28(3):235-45. PubMed ID: 10862029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
    Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
    Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic aberrations and the development of uterine leiomyomata.
    El-Gharib MN; Elsobky ES
    J Obstet Gynaecol Res; 2010 Feb; 36(1):101-7. PubMed ID: 20178534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene.
    Ptacek T; Song C; Walker CL; Sell SM
    Cancer Genet Cytogenet; 2007 Apr; 174(2):116-20. PubMed ID: 17452252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in human uterine leiomyomas.
    Martel KM; Ko AC; Christman GM; Stribley JM
    Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata.
    Hayden MA; Ordulu Z; Gallagher CS; Quade BJ; Anchan RM; Middleton NR; Srouji SS; Stewart EA; Morton CC
    Cancer Genet; 2018 Apr; 222-223():1-8. PubMed ID: 29666002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal interval defined on 7q in uterine leiomyoma.
    Sell SM; Tullis C; Stracner D; Song CY; Gewin J
    Cancer Genet Cytogenet; 2005 Feb; 157(1):67-9. PubMed ID: 15676150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Uterine Fibroid Etiology.
    McWilliams MM; Chennathukuzhi VM
    Semin Reprod Med; 2017 Mar; 35(2):181-189. PubMed ID: 28278535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
    Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC
    Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
    Crabtree JS; Jelinsky SA; Harris HA; Choe SE; Cotreau MM; Kimberland ML; Wilson E; Saraf KA; Liu W; McCampbell AS; Dave B; Broaddus RR; Brown EL; Kao W; Skotnicki JS; Abou-Gharbia M; Winneker RC; Walker CL
    Cancer Res; 2009 Aug; 69(15):6171-8. PubMed ID: 19622772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.
    Xing YP; Powell WL; Morton CC
    Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leiomyomata: heritability and cytogenetic studies.
    Ligon AH; Morton CC
    Hum Reprod Update; 2001; 7(1):8-14. PubMed ID: 11212080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in uterine fibroids - a new direction for pharmacological intervention?
    Markowski DN; Holzmann C; Bullerdiek J
    Expert Opin Ther Targets; 2015; 19(11):1485-94. PubMed ID: 26293838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
    Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; GirĂ£o MJ; Nishimura E; Baracat EC; Silva ID
    Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Association Studies in Uterine Fibroids: Risk Alleles Presage the Path to Personalized Therapies.
    Gallagher CS; Morton CC
    Semin Reprod Med; 2016 Jul; 34(4):235-41. PubMed ID: 27513025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.